Related Experiment Video
Updated: Dec 11, 2025

09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.2K
Chimeric antigen receptor T cells are vulnerable to immunosuppressive mechanisms present within the tumor
Gregory L Beatty1, Edmund K Moon2
1Abramson Cancer Center; Department of Medicine; Division of Hematology-Oncology; University of Pennsylvania Perelman School of Medicine ; Philadelphia, PA USA.
Oncoimmunology
|May 6, 2015
Abstract:
Chimeric antigen receptor (CAR) modified T cells have shown early promise in hematological malignancies. However, in solid malignancies CAR T cells must overcome a distinct immunosuppressive microenvironment which may compromise their capacity to mediate antitumor activity.
Keywords:
CAR, chimeric antigen receptorLag3, lymphocyte-activation gene 3PD1, programmed cell death 1PDL1, programmed death ligand 1TIM3, T cell immunoglobulin domain and mucin domain 3adoptive cell therapycancerchimeric antigen receptor T cellsimmune checkpoint moleculestumor microenvironment
